Ruxolitinib
Ruxolitinib ATC Code L01EJ01 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Janus-associated kinase (JAK) inhibitors - Ruxolitinib
Latin | Ruxolitinibum |
---|---|
Routes | Oral, topical |
Pregnancy category | C |
FDA Approval Date | 2011-11-16 |
EMA Approval Date | 2012-08-23 |
Molecular Formula | C17H18N6 |
Molecular Weight | 306.36502 g/mol |
CAS Number | 941678-49-5 |